Myriad Genetics Inc $36.86

down -0.19


30/7/2014 02:18 PM  |  NASDAQ : MYGN  
Industries : Diversified Services / Research Services
Get Trend Analysis Icon Get MYGN Trend Analysis - it has outperformed the S&P 500 by 5%

Partner Headlines

  1. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest ...

    Benzinga
  2. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  3. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  4. Novo, Other Medicals Display Healthy Action

    IBD
  5. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  6. MYRIAD GENETICS

    IBD
  7. Quiet Session Intensifies As Stocks Hit Session Lows

    IBD
  8. Stocks Extend Losses; AerCap Hits High On Earnings

    IBD
  9. Myriad Genetics and UnitedHealthcare Sign 3 Yr Deal To Make Cancer Tests ...

    Benzinga
  10. Earnings Scheduled For May 6, 2014

    Benzinga
  11. Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting

    IBD
  12. Why I Bought Myriad Genetics (MYGN)

    GuruFocus
  13. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest ...

    Benzinga
  14. Myriad Genetics Is Saving Lives With New Products

    IBD
  15. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  16. Myriad, Tata Motors Among RS Leaders In Correction

    IBD
  17. UPDATE: Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)

    Benzinga
  18. Avis Budget Leads 5 IBD 50 Stocks Holding Up Well

    IBD
  19. Stocks Jump, Then Trim Gains; Anadarko, Align Rock Ahead

    IBD
  20. Myriad soars to a 5-year high

    IBD
  21. Myriad Gaps Up To High On Reimbursement Rate Change

    IBD
  22. Indexes Extend Win Streak As S&P 500 Marks New High

    IBD
  23. Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares ...

    Benzinga
  24. Indexes Hold Modest Gains; Under Armour On The Move

    IBD
  25. Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike ...

    Benzinga
  26. Indexes Edge Higher; Rubicon Project Soars In Debut

    IBD
  27. Myriad Genetics Soars On CMS Reimbursement Increase

    IBD
  28. Mid-Morning Market Update: Markets Flat; Monsanto Earnings Beat Street ...

    Benzinga
  29. Benzinga's Volume Movers

    Benzinga
  30. Stocks Whittle Opening Gains; Apollo Tumbles, Despite Upgrade

    IBD
  31. Morning Market Movers

    Benzinga
  32. Jobs Data Trim Stock Futures; Myriad Genetics Spikes

    IBD
  33. J.P. Morgan Reinstates Underweight Rating on Myriad Over LT Outlook Concerns

    Benzinga
  34. Top 4 Stocks In The Research Services Industry With The Lowest PEG Ratio

    Benzinga
  35. Myriad falls on rival product

    IBD
  36. General Motors, Tesla Motors Under Late Pressure

    IBD
  37. Stocks Worsen In Late Trade; Ubiquiti Gains

    IBD
  38. Mid-Day Market Update: Men's Wearhouse To Acquire Jos. A. Bank For $65/Share; ...

    Benzinga
  39. Market Rallies; Green Mountain Changes Its Name

    IBD
  40. Mid Morning Losers for March 11th, 2014

    Benzinga
  41. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  42. Mid-Morning Market Update: Markets Edge Lower; American Eagle Issues Weak ...

    Benzinga
  43. Morning Market Losers

    Benzinga
  44. Stocks Futures Effectively Flat; Boyd Gaming Up, Myriad Dives

    IBD
  45. Benzinga's Top #PreMarket Losers

    Benzinga
  46. Medical Research Providers Ride Higher With Biotechs

    IBD
  47. Investing Like Martin Zweig: Growth With A Conservative Streak

    Benzinga
  48. US Stock Futures Up; All Eyes On Jobs Report

    Benzinga
  49. Mid-Afternoon Market Update: Sprint Rises on News it Has the Financing ...

    Benzinga
  50. Mid-Day Market Update: CH Robinson Shares Drop On Downbeat Results; Tableau ...

    Benzinga
Trading Center